An Kang Li
Director of Finance/CFO chez BRII BIOSCIENCES LIMITED
Fortune : 106 978 $ au 31/03/2024
Profil
An Kang Li is currently working as the CFO, Joint Secretary & Executive Director at Brii Biosciences Ltd.
(China) since 2022.
He is also serving as the Chief Financial & Strategy Officer at Brii Biosciences Ltd.
Additionally, Dr. Li has previously worked as an Executive Director in the Corporate Finance Department at Goldman Sachs Gao Hua Securities Co., Ltd.
from 2018 to 2019.
He has also held the position of Director of Business Development at MSD R&D (China) Co. Ltd.
from 2016 to 2017.
Dr. Li has experience as a Research Associate at The Salk Institute for Biological Studies from 2007 to 2009.
He has worked as an Associate at Davis Polk & Wardwell LLP from 2012 to 2014 and as an Associate at Ropes & Gray LLP in their Shanghai Office from 2014 to 2016.
Dr. Li has also served as the Chief Financial Officer at Terns China Biotechnology Co. Ltd.
from 2019 to 2020.
In terms of education, Dr. Li holds a graduate degree from the National University of Singapore (2002), a doctorate degree from Baylor College of Medicine (2007), an undergraduate degree from Fudan University (1999), and a graduate degree from The University of Chicago Law School (2012).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BRII BIOSCIENCES LIMITED
0,13% | 21/09/2023 | 920 082 ( 0,13% ) | 106 978 $ | 31/03/2024 |
Postes actifs de An Kang Li
| Sociétés | Poste | Début |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Director of Finance/CFO | 01/09/2020 |
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Director of Finance/CFO | - |
Anciens postes connus de An Kang Li
| Sociétés | Poste | Fin |
|---|---|---|
Terns China Biotechnology Co. Ltd.
 Terns China Biotechnology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Terns Pharmaceuticals, Inc., Terns China Biotechnology Co., Ltd. develops single agent and combination therapies. The private company is based in Wuhan, China. | Director of Finance/CFO | 01/08/2020 |
Goldman Sachs Gao Hua Securities Co., Ltd.
 Goldman Sachs Gao Hua Securities Co., Ltd. Investment Banks/BrokersFinance Goldman Sachs Gao Hua Securities Co., Ltd. (GS-GHS) is a Beijing-based securities firm established in 2004 as a joint venture between the leading global investment banking, securities and investment management firm Goldman Sachs Group, Inc. (NYSE: GS) and the domestic securities firm Beijing Gao Hua Securities Co. Ltd., led by China-born banker Fang Fenglei. The Lenovo Group, China's largest computer manufacturer, was a key investor in GS-GHS, which was set-up through the acquisition of the operating license of the failed Hainan Securities. The presence of Goldman Sachs in Beijing dates back to 1993, and the creation of GS-GHS gave them a first-mover advantage in the Chinese securities market. GS-GHS offers a wide range of investment banking services to clients based in mainland China, including domestic securities brokerage and proprietary trading in equity, fixed income, currency and commodities. The firm underwrites locally-listed A-share transactions as well as RMB-denominated corporate bonds and convertible bonds. They also provide domestic financial advisory and other related services. The management team comprises Chinese and international investment bankers and securities professionals. | Corporate Officer/Principal | 01/01/2019 |
| MSD R&D (China) Co. Ltd. | Corporate Officer/Principal | 01/12/2017 |
Ropes & Gray LLP
 Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/09/2016 |
Davis Polk & Wardwell LLP
 Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Davis Polk & Wardwell LLP provides legal services. It offers legal solutions to areas such as capital markets, mergers and acquisitions, credit, insolvency, and restructuring, investment management, tax, and litigation. The company was founded by Francis N. Bangs in 1849 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/08/2014 |
Formation de An Kang Li
| National University of Singapore | Graduate Degree |
| Baylor College of Medicine | Doctorate Degree |
| Fudan University | Undergraduate Degree |
| The University of Chicago Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRII BIOSCIENCES LIMITED | Commercial Services |
| Entreprise privées | 6 |
|---|---|
Davis Polk & Wardwell LLP
Davis Polk & Wardwell LLP Miscellaneous Commercial ServicesCommercial Services Davis Polk & Wardwell LLP provides legal services. It offers legal solutions to areas such as capital markets, mergers and acquisitions, credit, insolvency, and restructuring, investment management, tax, and litigation. The company was founded by Francis N. Bangs in 1849 and is headquartered in New York, NY. | Commercial Services |
Goldman Sachs Gao Hua Securities Co., Ltd.
Goldman Sachs Gao Hua Securities Co., Ltd. Investment Banks/BrokersFinance Goldman Sachs Gao Hua Securities Co., Ltd. (GS-GHS) is a Beijing-based securities firm established in 2004 as a joint venture between the leading global investment banking, securities and investment management firm Goldman Sachs Group, Inc. (NYSE: GS) and the domestic securities firm Beijing Gao Hua Securities Co. Ltd., led by China-born banker Fang Fenglei. The Lenovo Group, China's largest computer manufacturer, was a key investor in GS-GHS, which was set-up through the acquisition of the operating license of the failed Hainan Securities. The presence of Goldman Sachs in Beijing dates back to 1993, and the creation of GS-GHS gave them a first-mover advantage in the Chinese securities market. GS-GHS offers a wide range of investment banking services to clients based in mainland China, including domestic securities brokerage and proprietary trading in equity, fixed income, currency and commodities. The firm underwrites locally-listed A-share transactions as well as RMB-denominated corporate bonds and convertible bonds. They also provide domestic financial advisory and other related services. The management team comprises Chinese and international investment bankers and securities professionals. | Finance |
Ropes & Gray LLP
Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Commercial Services |
| MSD R&D (China) Co. Ltd. | |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
Terns China Biotechnology Co. Ltd.
Terns China Biotechnology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Terns Pharmaceuticals, Inc., Terns China Biotechnology Co., Ltd. develops single agent and combination therapies. The private company is based in Wuhan, China. | Commercial Services |
